Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

Osteoblastic Factors in Prostate Cancer Bone Metastasis.

Lin SC, Yu-Lee LY, Lin SH.

Curr Osteoporos Rep. 2018 Sep 10. doi: 10.1007/s11914-018-0480-6. [Epub ahead of print] Review.

PMID:
30203251
2.

Organelle-Derived Acetyl-CoA Promotes Prostate Cancer Cell Survival, Migration, and Metastasis via Activation of Calmodulin Kinase II.

Yu G, Cheng CJ, Lin SC, Lee YC, Frigo DE, Yu-Lee LY, Gallick GE, Titus MA, Nutt LK, Lin SH.

Cancer Res. 2018 May 15;78(10):2490-2502. doi: 10.1158/0008-5472.CAN-17-2392. Epub 2018 Mar 13.

PMID:
29535221
3.

Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.

Yu-Lee LY, Yu G, Lee YC, Lin SC, Pan J, Pan T, Yu KJ, Liu B, Creighton CJ, Rodriguez-Canales J, Villalobos PA, Wistuba II, de Nadal E, Posas F, Gallick GE, Lin SH.

Cancer Res. 2018 Jun 1;78(11):2911-2924. doi: 10.1158/0008-5472.CAN-17-1051. Epub 2018 Mar 7.

PMID:
29514796
4.

Development of a kelp powder (Thallus laminariae) Standard Reference Material.

Yu LL, Browning JF, Burdette CQ, Caceres GC, Chieh KD, Davis WC, Kassim BL, Long SE, Murphy KE, Oflaz R, Paul RL, Sharpless KE, Wood LJ, Yen JH, Zeisler R.

Anal Bioanal Chem. 2018 Feb;410(4):1265-1278. doi: 10.1007/s00216-017-0766-z. Epub 2017 Dec 9.

PMID:
29222652
5.

BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation.

Pan T, Lin SC, Yu KJ, Yu G, Song JH, Lewis VO, Bird JE, Moon B, Lin PP, Tannir NM, Jonasch E, Wood CG, Gallick GE, Yu-Lee LY, Lin SH, Satcher RL.

Neoplasia. 2018 Jan;20(1):32-43. doi: 10.1016/j.neo.2017.11.002. Epub 2017 Nov 27.

6.

Cabozantinib-induced osteoblast secretome promotes survival and migration of metastatic prostate cancer cells in bone.

Yu KJ, Li JK, Lee YC, Yu G, Lin SC, Pan T, Satcher RL, Titus MA, Yu-Lee LY, Weng WH, Gallick GE, Lin SH.

Oncotarget. 2017 Aug 24;8(43):74987-75006. doi: 10.18632/oncotarget.20489. eCollection 2017 Sep 26.

7.

SI traceable determination of arsenic species in kelp (Thallus laminariae).

Yu LL, Stanoyevitch RC, Zeisler R.

Anal Methods. 2017 Aug;9(29):4267-4274. doi: 10.1039/C7AY01111C. Epub 2017 Jun 26.

8.

Proteomics Profiling of Exosomes from Primary Mouse Osteoblasts under Proliferation versus Mineralization Conditions and Characterization of Their Uptake into Prostate Cancer Cells.

Bilen MA, Pan T, Lee YC, Lin SC, Yu G, Pan J, Hawke D, Pan BF, Vykoukal J, Gray K, Satcher RL, Gallick GE, Yu-Lee LY, Lin SH.

J Proteome Res. 2017 Aug 4;16(8):2709-2728. doi: 10.1021/acs.jproteome.6b00981. Epub 2017 Jul 18.

9.

LRP1-Dependent BMPER Signaling Regulates Lipopolysaccharide-Induced Vascular Inflammation.

Lockyer P, Mao H, Fan Q, Li L, Yu-Lee LY, Eissa NT, Patterson C, Xie L, Pi X.

Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1524-1535. doi: 10.1161/ATVBAHA.117.309521. Epub 2017 Jun 8.

10.

Endothelial-to-Osteoblast Conversion Generates Osteoblastic Metastasis of Prostate Cancer.

Lin SC, Lee YC, Yu G, Cheng CJ, Zhou X, Chu K, Murshed M, Le NT, Baseler L, Abe JI, Fujiwara K, deCrombrugghe B, Logothetis CJ, Gallick GE, Yu-Lee LY, Maity SN, Lin SH.

Dev Cell. 2017 Jun 5;41(5):467-480.e3. doi: 10.1016/j.devcel.2017.05.005.

11.

Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway.

Zeng H, Ortiz A, Shen PF, Cheng CJ, Lee YC, Yu G, Lin SC, Creighton CJ, Yu-Lee LY, Lin SH.

Oncotarget. 2017 Feb 7;8(6):10145-10160. doi: 10.18632/oncotarget.14358.

12.

Separation, Sizing, and Quantitation of Engineered Nanoparticles in an Organism Model Using Inductively Coupled Plasma Mass Spectrometry and Image Analysis.

Johnson ME, Hanna SK, Montoro Bustos AR, Sims CM, Elliott LC, Lingayat A, Johnston AC, Nikoobakht B, Elliott JT, Holbrook RD, Scott KC, Murphy KE, Petersen EJ, Yu LL, Nelson BC.

ACS Nano. 2017 Jan 24;11(1):526-540. doi: 10.1021/acsnano.6b06582. Epub 2016 Dec 28.

13.

Surface Degradation and Nanoparticle Release of a Commercial Nanosilica/Polyurethane Coating Under UV Exposure.

Jacobs DS, Huang SR, Cheng YL, Rabb SA, Gorham JM, Krommenhoek PJ, Yu LL, Nguyen T, Sung L.

J Coat Technol Res. 2016 Sep;13(5):735-751. Epub 2016 Jul 13.

14.

Therapeutic relevance of the protein phosphatase 2A in cancer.

Cunningham CE, Li S, Vizeacoumar FS, Bhanumathy KK, Lee JS, Parameswaran S, Furber L, Abuhussein O, Paul JM, McDonald M, Templeton SD, Shukla H, El Zawily AM, Boyd F, Alli N, Mousseau DD, Geyer R, Bonham K, Anderson DH, Yan J, Yu-Lee LY, Weaver BA, Uppalapati M, Ruppin E, Sablina A, Freywald A, Vizeacoumar FJ.

Oncotarget. 2016 Sep 20;7(38):61544-61561. doi: 10.18632/oncotarget.11399.

15.

Dynamic Phosphorylation of NudC by Aurora B in Cytokinesis.

Weiderhold KN, Fadri-Moskwik M, Pan J, Nishino M, Chuang C, Deeraksa A, Lin SH, Yu-Lee LY.

PLoS One. 2016 Apr 13;11(4):e0153455. doi: 10.1371/journal.pone.0153455. eCollection 2016.

16.

Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer.

Lee YC, Lin SC, Yu G, Cheng CJ, Liu B, Liu HC, Hawke DH, Parikh NU, Varkaris A, Corn P, Logothetis C, Satcher RL, Yu-Lee LY, Gallick GE, Lin SH.

Cancer Res. 2015 Nov 15;75(22):4949-59. doi: 10.1158/0008-5472.CAN-15-1215. Epub 2015 Nov 3.

17.

Cadherin-11 endocytosis through binding to clathrin promotes cadherin-11-mediated migration in prostate cancer cells.

Satcher RL, Pan T, Bilen MA, Li X, Lee YC, Ortiz A, Kowalczyk AP, Yu-Lee LY, Lin SH.

J Cell Sci. 2015 Dec 15;128(24):4629-41. doi: 10.1242/jcs.176081. Epub 2015 Oct 30.

18.

An approach for identification and determination of arsenic species in the extract of kelp.

Yu LL, Wei C, Zeisler R, Tong J, Oflaz R, Bao H, Wang J.

Anal Bioanal Chem. 2015 May;407(12):3517-24. doi: 10.1007/s00216-015-8567-8. Epub 2015 Mar 3.

PMID:
25732093
19.

Secretome analysis of an osteogenic prostate tumor identifies complex signaling networks mediating cross-talk of cancer and stromal cells within the tumor microenvironment.

Lee YC, Gajdosik MS, Josic D, Clifton JG, Logothetis C, Yu-Lee LY, Gallick GE, Maity SN, Lin SH.

Mol Cell Proteomics. 2015 Mar;14(3):471-83. doi: 10.1074/mcp.M114.039909. Epub 2014 Dec 19.

20.

Angiomotin is a novel component of cadherin-11/β-catenin/p120 complex and is critical for cadherin-11-mediated cell migration.

Ortiz A, Lee YC, Yu G, Liu HC, Lin SC, Bilen MA, Cho H, Yu-Lee LY, Lin SH.

FASEB J. 2015 Mar;29(3):1080-91. doi: 10.1096/fj.14-261594. Epub 2014 Dec 2.

21.

The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor.

Karlin KL, Mondal G, Hartman JK, Tyagi S, Kurley SJ, Bland CS, Hsu TY, Renwick A, Fang JE, Migliaccio I, Callaway C, Nair A, Dominguez-Vidana R, Nguyen DX, Osborne CK, Schiff R, Yu-Lee LY, Jung SY, Edwards DP, Hilsenbeck SG, Rosen JM, Zhang XH, Shaw CA, Couch FJ, Westbrook TF.

Cell Rep. 2014 Nov 20;9(4):1318-32. doi: 10.1016/j.celrep.2014.10.011. Epub 2014 Nov 6.

22.

RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival.

Yu G, Lee YC, Cheng CJ, Wu CF, Song JH, Gallick GE, Yu-Lee LY, Kuang J, Lin SH.

Mol Cancer Res. 2015 Feb;13(2):348-57. doi: 10.1158/1541-7786.MCR-14-0384-T. Epub 2014 Sep 4.

23.

Certification of elements in and use of standard reference material 3280 multivitamin/multielement tablets.

Turk GC, Sharpless KE, Cleveland D, Jongsma C, Mackey EA, Marlow AF, Oflaz R, Paul RL, Sieber JR, Thompson RQ, Wood LJ, Yu LL, Zeisler R, Wise SA, Yen JH, Christopher SJ, Day RD, Long SE, Greene E, Harnly J, Ho IP, Betz JM.

J AOAC Int. 2013 Nov-Dec;96(6):1281-7.

PMID:
24645505
24.

The transcription factor E74-like factor 4 suppresses differentiation of proliferating CD4+ T cells to the Th17 lineage.

Lee PH, Puppi M, Schluns KS, Yu-Lee LY, Dong C, Lacorazza HD.

J Immunol. 2014 Jan 1;192(1):178-88. doi: 10.4049/jimmunol.1301372. Epub 2013 Nov 20.

25.

NudC deacetylation regulates mitotic progression.

Chuang C, Pan J, Hawke DH, Lin SH, Yu-Lee LY.

PLoS One. 2013 Sep 19;8(9):e73841. doi: 10.1371/journal.pone.0073841. eCollection 2013.

26.

Fast and accurate determination of K, Ca, and Mg in human serum by sector field ICP-MS.

Yu LL, Davis WC, Nuevo Ordonez Y, Long SE.

Anal Bioanal Chem. 2013 Nov;405(27):8761-8. doi: 10.1007/s00216-013-7320-4. Epub 2013 Sep 1.

PMID:
23995507
27.

Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasis.

Lee YC, Bilen MA, Yu G, Lin SC, Huang CF, Ortiz A, Cho H, Song JH, Satcher RL, Kuang J, Gallick GE, Yu-Lee LY, Huang W, Lin SH.

Mol Cancer Res. 2013 Nov;11(11):1401-11. doi: 10.1158/1541-7786.MCR-13-0108. Epub 2013 Aug 2.

28.

RSK promotes G2/M transition through activating phosphorylation of Cdc25A and Cdc25B.

Wu CF, Liu S, Lee YC, Wang R, Sun S, Yin F, Bornmann WG, Yu-Lee LY, Gallick GE, Zhang W, Lin SH, Kuang J.

Oncogene. 2014 May 1;33(18):2385-94. doi: 10.1038/onc.2013.182. Epub 2013 May 27.

29.

Salivary antigen-5/CAP family members are Cu2+-dependent antioxidant enzymes that scavenge O₂₋. and inhibit collagen-induced platelet aggregation and neutrophil oxidative burst.

Assumpção TC, Ma D, Schwarz A, Reiter K, Santana JM, Andersen JF, Ribeiro JM, Nardone G, Yu LL, Francischetti IM.

J Biol Chem. 2013 May 17;288(20):14341-61. doi: 10.1074/jbc.M113.466995. Epub 2013 Apr 5.

30.

Targeting constitutively activated β1 integrins inhibits prostate cancer metastasis.

Lee YC, Jin JK, Cheng CJ, Huang CF, Song JH, Huang M, Brown WS, Zhang S, Yu-Lee LY, Yeh ET, McIntyre BW, Logothetis CJ, Gallick GE, Lin SH.

Mol Cancer Res. 2013 Apr;11(4):405-17. doi: 10.1158/1541-7786.MCR-12-0551. Epub 2013 Jan 21.

31.

Real-time size discrimination and elemental analysis of gold nanoparticles using ES-DMA coupled to ICP-MS.

Elzey S, Tsai DH, Yu LL, Winchester MR, Kelley ME, Hackley VA.

Anal Bioanal Chem. 2013 Mar;405(7):2279-88. doi: 10.1007/s00216-012-6617-z. Epub 2013 Jan 22.

PMID:
23338753
32.

Identifying acetylated proteins in mitosis.

Chuang C, Yu-Lee LY.

Methods Mol Biol. 2012;909:181-204. doi: 10.1007/978-1-61779-959-4_13.

PMID:
22903717
33.

Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis.

Deeraksa A, Pan J, Sha Y, Liu XD, Eissa NT, Lin SH, Yu-Lee LY.

Oncogene. 2013 Jun 13;32(24):2973-83. doi: 10.1038/onc.2012.309. Epub 2012 Aug 13.

34.

Characterization of perchlorate in a new frozen human urine standard reference material.

Yu LL, Jarrett JM, Davis WC, Kilpatrick EL, Oflaz R, Turk GC, Leber DD, Valentin L, Morel-Espinosa M, Blount BC.

Anal Bioanal Chem. 2012 Oct;404(6-7):1877-86. doi: 10.1007/s00216-012-6263-5. Epub 2012 Aug 1.

35.

Aurora B is regulated by acetylation/deacetylation during mitosis in prostate cancer cells.

Fadri-Moskwik M, Weiderhold KN, Deeraksa A, Chuang C, Pan J, Lin SH, Yu-Lee LY.

FASEB J. 2012 Oct;26(10):4057-67. doi: 10.1096/fj.12-206656. Epub 2012 Jul 2.

36.

Quantification of ligand packing density on gold nanoparticles using ICP-OES.

Elzey S, Tsai DH, Rabb SA, Yu LL, Winchester MR, Hackley VA.

Anal Bioanal Chem. 2012 Apr;403(1):145-9. doi: 10.1007/s00216-012-5830-0. Epub 2012 Feb 18.

PMID:
22349346
37.

Preliminary evaluation of a microwave-assisted metal-labeling strategy for quantification of peptides via RPLC-ICP-MS and the method of standard additions.

Christopher SJ, Kilpatrick EL, Yu LL, Davis WC, Adair BM.

Talanta. 2012 Jan 15;88:749-58. doi: 10.1016/j.talanta.2011.11.064. Epub 2011 Nov 26.

PMID:
22265570
38.

Aberrant expression of katanin p60 in prostate cancer bone metastasis.

Ye X, Lee YC, Choueiri M, Chu K, Huang CF, Tsai WW, Kobayashi R, Logothetis CJ, Yu-Lee LY, Lin SH.

Prostate. 2012 Feb;72(3):291-300. doi: 10.1002/pros.21431. Epub 2011 Jun 16.

39.

BMP4 promotes prostate tumor growth in bone through osteogenesis.

Lee YC, Cheng CJ, Bilen MA, Lu JF, Satcher RL, Yu-Lee LY, Gallick GE, Maity SN, Lin SH.

Cancer Res. 2011 Aug 1;71(15):5194-203. doi: 10.1158/0008-5472.CAN-10-4374. Epub 2011 Jun 13.

40.

Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling.

Qin J, Chen X, Yu-Lee LY, Tsai MJ, Tsai SY.

Cancer Res. 2010 Nov 1;70(21):8812-21. doi: 10.1158/0008-5472.CAN-10-0551. Epub 2010 Oct 26.

41.

Acetylation of RNA processing proteins and cell cycle proteins in mitosis.

Chuang C, Lin SH, Huang F, Pan J, Josic D, Yu-Lee LY.

J Proteome Res. 2010 Sep 3;9(9):4554-64. doi: 10.1021/pr100281h.

42.

Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts.

Huang CF, Lira C, Chu K, Bilen MA, Lee YC, Ye X, Kim SM, Ortiz A, Wu FL, Logothetis CJ, Yu-Lee LY, Lin SH.

Cancer Res. 2010 Jun 1;70(11):4580-9. doi: 10.1158/0008-5472.CAN-09-3016. Epub 2010 May 18.

43.

Chemical attribution of corroded coins using X-ray fluorescence and lead isotope ratios: a case study from first century Judaea.

Epstein MS, Hendin DB, Yu LL, Bower NW.

Appl Spectrosc. 2010 Apr;64(4):384-90. doi: 10.1366/000370210791114211.

PMID:
20412622
44.

Translational considerations for cancer nanomedicine.

Stern ST, Hall JB, Yu LL, Wood LJ, Paciotti GF, Tamarkin L, Long SE, McNeil SE.

J Control Release. 2010 Sep 1;146(2):164-74. doi: 10.1016/j.jconrel.2010.04.008. Epub 2010 Apr 10.

45.

Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts.

Lee YC, Huang CF, Murshed M, Chu K, Araujo JC, Ye X, deCrombrugghe B, Yu-Lee LY, Gallick GE, Lin SH.

Oncogene. 2010 Jun 3;29(22):3196-207. doi: 10.1038/onc.2010.73. Epub 2010 Mar 15.

46.

Androgen depletion up-regulates cadherin-11 expression in prostate cancer.

Lee YC, Cheng CJ, Huang M, Bilen MA, Ye X, Navone NM, Chu K, Kao HH, Yu-Lee LY, Wang Z, Lin SH.

J Pathol. 2010 May;221(1):68-76. doi: 10.1002/path.2687.

47.

Methods for the separation and quantification of arsenic species in SRM 2669: arsenic species in frozen human urine.

Davis WC, Zeisler R, Sieber JR, Yu LL.

Anal Bioanal Chem. 2010 Apr;396(8):3041-50. doi: 10.1007/s00216-010-3541-y. Epub 2010 Feb 26.

PMID:
20186533
48.

PICH and cotargeted Plk1 coordinately maintain prometaphase chromosome arm architecture.

Kurasawa Y, Yu-Lee LY.

Mol Biol Cell. 2010 Apr 1;21(7):1188-99. doi: 10.1091/mbc.E09-11-0950. Epub 2010 Feb 3.

49.

What were they drinking? A critical study of the radium ore revigator.

Epstein MS, Miles DG Jr, Yu LL.

Appl Spectrosc. 2009 Dec;63(12):1406-9. doi: 10.1366/000370209790109003. No abstract available.

PMID:
20030988
50.

Characterization of SiGe films for use as a National Institute of Standards and Technology Microanalysis Reference Material (RM 8905).

Marinenko RB, Turner S, Simons DS, Rabb SA, Zeisler RL, Yu LL, Newbury DE, Paul RL, Ritchie NW, Leigh SD, Winchester MR, Richter LJ, Meier DC, Scott KC, Klinedinst D, Small JA.

Microsc Microanal. 2010 Feb;16(1):1-12. doi: 10.1017/S1431927609991231. Epub 2009 Dec 24.

PMID:
20030913

Supplemental Content

Loading ...
Support Center